Nexus Oncology Ltd   Report issue

For profit Phase 2
Founded: Edinburgh United Kingdom (1999)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00559624
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

acadesine (arasine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1